{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:22:53Z","timestamp":1781076173634,"version":"3.54.1"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03172-0","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T08:02:55Z","timestamp":1719561775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vulvar Crohn\u2019s disease: a retrospective chart review at a single academic institution"],"prefix":"10.1007","volume":"316","author":[{"given":"Mallory L.","family":"Zaino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"Pixley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita O.","family":"Pichardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"issue":"7","key":"3172_CR1","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/MEG.0000000000000879","volume":"29","author":"L Boxhoorn","year":"2017","unstructured":"Boxhoorn L, Stoof TJ, de Meij T et al (2017) Clinical experience and diagnostic algorithm of vulval Crohn\u2019s disease. Eur J Gastroenterol Hepatol Jul 29(7):838\u2013843. https:\/\/doi.org\/10.1097\/MEG.0000000000000879","journal-title":"Eur J Gastroenterol Hepatol Jul"},{"issue":"12","key":"3172_CR2","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1111\/jgh.14291","volume":"33","author":"B Bhoyrul","year":"2018","unstructured":"Bhoyrul B, Lyon C (2018) Crohn\u2019s disease of the vulva: a prospective study. J Gastroenterol Hepatol Dec 33(12):1969\u20131974. https:\/\/doi.org\/10.1111\/jgh.14291","journal-title":"J Gastroenterol Hepatol Dec"},{"issue":"4","key":"3172_CR3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.jaad.2014.04.002","volume":"71","author":"DJ Kurtzman","year":"2014","unstructured":"Kurtzman DJ, Jones T, Lian F, Peng LS (2014) Metastatic Crohn\u2019s disease: a review and approach to therapy. J Am Acad Dermatol Oct 71(4):804\u2013813. https:\/\/doi.org\/10.1016\/j.jaad.2014.04.002","journal-title":"J Am Acad Dermatol Oct"},{"issue":"11","key":"3172_CR4","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.14309\/ajg.0000000000001502","volume":"11 01","author":"JM Cho","year":"2021","unstructured":"Cho JM, Loftus EV, Bruining DH et al (2021) Vulvar Crohn\u2019s Disease: clinical features and outcomes. Am J Gastroenterol 11 01(11):2296\u20132299. https:\/\/doi.org\/10.14309\/ajg.0000000000001502","journal-title":"Am J Gastroenterol"},{"key":"3172_CR5","doi-asserted-by":"publisher","unstructured":"Vaid RM, Cohen BA (2010) Cutaneous Crohn\u2019s disease in the pediatric population. Pediatr Dermatol. May-Jun 2010;27(3):279\u2009\u2013\u200981. https:\/\/doi.org\/10.1111\/j.1525-1470.2010.01138.x","DOI":"10.1111\/j.1525-1470.2010.01138.x"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03172-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03172-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03172-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T20:37:25Z","timestamp":1725914245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03172-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":5,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["3172"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03172-0","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Wake Forest Institutional Review Board (IRB00090048). Informed consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Feldman has received research, speaking and\/or consulting support from AbbVie, Accordant, Almirall, Alvotech, Amgen, Arcutis, Arena, Argenx, Biocon, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, Eli Lilly and Company, Eurofins, Forte, Galderma, Helsinn, Janssen, Leo Pharma, Micreos, Mylan, Novartis, Ono, Ortho Dermatology, Pfizer, Regeneron, Samsung, Sanofi, Sun Pharma, UCB, Verrica, Voluntis, and vTv Therapeutics. He is founder and part owner of Causa Research and holds stock in Sensal Health. Pichardo worked at the advisory board for Novartis. Zaino and Pixley have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"439"}}